These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3326424)

  • 21. [Antimycotic drugs under continuous renal replacement therapy].
    Muhl E
    Mycoses; 2005; 48 Suppl 1():56-60. PubMed ID: 15826289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of drug removal by continuous hemofiltration.
    Lau AH; Kronfol NO
    Int J Artif Organs; 1994 Jul; 17(7):373-8. PubMed ID: 7806423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solute and water transport during continuous arteriovenous hemofiltration (CAVH).
    Ronco C; Brendolan A; Bragantini L; Fabris A; Feriani M; Chiaramonte S; Dell'Aquila R; Milan M; La Greca G
    Int J Artif Organs; 1987 May; 10(3):179-84. PubMed ID: 3610369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of factors affecting drug extraction during continuous hemofiltration and hemodiafiltration, and the contribution of extraction to systemic clearance].
    Suzuki F; Hanada K; Motoki M; Ogata H
    Yakugaku Zasshi; 2012; 132(4):517-23. PubMed ID: 22465930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sieving characteristics of a new polysulfone hemofilter for use with continuous arterio-venous hemofiltration.
    Kaplan AA; Golper TA
    Int J Artif Organs; 1987 Nov; 10(6):357-60. PubMed ID: 3443518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of theophylline clearance during continuous arteriovenous hemofiltration.
    Horton MW; Godley PJ; Moore ES; Fineg J; Gillespie WR
    Artif Organs; 1990 Dec; 14(6):416-20. PubMed ID: 2281990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous hemofiltration.
    Ann Intern Med; 1984 Jul; 101(1):145-7. PubMed ID: 6732085
    [No Abstract]   [Full Text] [Related]  

  • 31. Which metabolites circulate?
    Loi CM; Smith DA; Dalvie D
    Drug Metab Dispos; 2013 May; 41(5):933-51. PubMed ID: 23454828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of sulfonamides by hemofiltration.
    Yu SS; Waters DH; Shen SH; Lempert KD; Gwilt PR
    Biopharm Drug Dispos; 1989; 10(2):173-85. PubMed ID: 2706317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-vs. post-dilutional hemofiltration.
    Lopot F; Válek A
    Clin Nephrol; 1979 Aug; 12(2):69-73. PubMed ID: 527273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation and first validation study on a simplified drug dosage algorithm for multiple organ failure patients.
    Kroh UF; Lennartz H
    Ren Fail; 1992; 14(4):579-85. PubMed ID: 1462011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemofiltration: determinants of drug loss and concentration.
    Clar A; Larson DF
    J Extra Corpor Technol; 1995 Sep; 27(3):158-63. PubMed ID: 10155361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of drugs by the new polyamide hemofilter FH77H during various in vitro conditions.
    Kroh UF; Dinges GK; Lukasewitz P; Steinhäusser WU; Holl TJ; Lennartz H
    Blood Purif; 1998; 16(1):49-56. PubMed ID: 9513763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Filtration rate and sieving coefficients of six different filters for continuous hemofiltration.
    Glöckner WM; Gerarts M
    Contrib Nephrol; 1991; 93():162-6. PubMed ID: 1802571
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on drug sieving coefficients and dosing adjustments during continuous renal replacement therapies.
    Golper TA
    Contrib Nephrol; 2001; (132):349-53. PubMed ID: 11395902
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug dosage during continuous hemofiltration: pharmacokinetics and practical implications.
    Kroh UF; Dehne M; el Abed K; Feussner KD; Hofmann W; Lennartz H
    Contrib Nephrol; 1991; 93():127-30. PubMed ID: 1802561
    [No Abstract]   [Full Text] [Related]  

  • 40. Free drug concentrations are constant in serial fractions of plasma ultrafiltrate.
    Judd RL; Pesce AJ
    Clin Chem; 1982 Jul; 28(7):1726-7. PubMed ID: 7083586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.